日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Molecular Signature of the Ubiquitin-Proteasome System for Forecasting Prognosis in Thyroid Carcinoma Patients.

泛素-蛋白酶体系统的分子特征可用于预测甲状腺癌患者的预后

Zeng Hong, Geng Xitong, Wan Hao, Qu Xiaoyu, Tang Shengwei, Zhang Ruiyu, Zhou Minqin, Yu Zichuan, Pan Jingying, Zheng Hao, Zhu Yanting, Huang Shuhan, Huang Da

LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior

LAMP3是一种与免疫行为相关的强效子宫内膜癌预后生物标志物。

Fu, Bidong; Zhou, Minqin; Geng, Xitong; Jiang, Yike; Zeng, Hong; Zhou, Xuanrui; Yu, Zichuan; Pan, Jingying; Zhu, Yanting; Zheng, Hao; Huang, Shuhan; Gong, Yiyang; Huang, Da; Zhong, Yanying

Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification

基于综合计算生物学和实验验证,鉴定出胶质瘤的可靠生物标志物LAPTM4A

Ding, Yongqi; Jiang, Yike; Zeng, Hong; Zhou, Minqin; Zhou, Xuanrui; Yu, Zichuan; Pan, Jingying; Geng, Xitong; Zhu, Yanting; Zheng, Hao; Huang, Shuhan; Gong, Yiyang; Huang, Huabin; Xiong, Chengfeng; Huang, Da

An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer

与上皮间质转化(EMT)相关的免疫生物标志物可作为膀胱癌预后和药物反应的预测因子。

Jiang, Yike; Yu, Zichuan; Zheng, Hao; Zhou, Xuanrui; Zhou, Minqin; Geng, Xitong; Zhu, Yanting; Huang, Shuhan; Gong, Yiyang; Guo, Liangyun

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity

研究发现RP2是胶质瘤的预后生物标志物,主要通过调节肿瘤免疫促进胶质瘤的发生发展。

Gong, Yiyang; Ke, Yun; Yu, Zichuan; Pan, Jingying; Zhou, Xuanrui; Jiang, Yike; Zhou, Minqin; Zeng, Hong; Geng, Xitong; Hu, Guowen